These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9466376)

  • 1. Obsessive-compulsive disorder: cerebral calcium deficiency as a possible etiologic/pathogenetic factor--a case study.
    Oken RJ
    Med Hypotheses; 1997 Dec; 49(6):513-4. PubMed ID: 9466376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive disorder: a neuronal membrane phospholipid hypothesis and concomitant therapeutic strategy.
    Oken RJ
    Med Hypotheses; 2001 Apr; 56(4):413-5. PubMed ID: 11339839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of renal function by angiotensin-converting enzyme inhibitors: effect of verapamil.
    Bitar R; Martín B; López-Novoa JM; Macías-Nuñez JF
    Nephron; 1997; 75(4):486-7. PubMed ID: 9127339
    [No Abstract]   [Full Text] [Related]  

  • 5. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates.
    Lochner C; Hemmings SM; Kinnear CJ; Niehaus DJ; Nel DG; Corfield VA; Moolman-Smook JC; Seedat S; Stein DJ
    Compr Psychiatry; 2005; 46(1):14-9. PubMed ID: 15714189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-channel blockers for hypertension--uncertainty continues.
    Cutler JA
    N Engl J Med; 1998 Mar; 338(10):679-81. PubMed ID: 9486999
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL; Henningsen NC; Fagher B; Thulin T; Hulthén UL
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.
    Koo MS; Kim EJ; Roh D; Kim CH
    Expert Rev Neurother; 2010 Feb; 10(2):275-90. PubMed ID: 20136383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual calcium-channel blocker therapy in the treatment of hypertension.
    Saseen JJ; Carter BL
    Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arguments for cerebral dysfunction in obsessive-compulsive disorder. A review and synthesis of the literature].
    Hantouche E; Guéguen B; Martinot JL; Gasnault J
    Encephale; 1990; 16(1):23-30. PubMed ID: 2184011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
    Messerli F; Frishman WH; Elliott WJ
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
    Koster M
    Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1509-13. PubMed ID: 3020442
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebral glucose metabolism in obsessive-compulsive hoarding.
    Saxena S; Brody AL; Maidment KM; Smith EC; Zohrabi N; Katz E; Baker SK; Baxter LR
    Am J Psychiatry; 2004 Jun; 161(6):1038-48. PubMed ID: 15169692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine.
    Zhang W; Wang Z
    Life Sci; 2001 May; 68(25):2769-79. PubMed ID: 11432443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of calcium channel blocker use with increased rate of acute myocardial infarction in patients with left ventricular dysfunction.
    Kostis JB; Lacy CR; Cosgrove NM; Wilson AC
    Am Heart J; 1997 May; 133(5):550-7. PubMed ID: 9141377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.